Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcomes and Prognostic Factors in Hepatopancreatoduodenectomy

NCT06631352 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT06631352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06631352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcomes and Prognostic Factors in Hepatopancreatoduodenectomy
Lead sponsor
Seoul National University Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2000
Completion date
May 31, 2024
Enrollment
50 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bile duct cancer, gall bladder cancer, hepatectomy, hepatopancreaticobiliary (hpb) malignancy, pancreatoduodenectomy